Canadian Rheumatology Association issues best practice statements and recommendation for choosing DMARD therapy after an inadequate response to TNF inhibitors.
Low back pain has ranked first among causes of disability for the last three decades. Back pain, however, is not inevitable, even if that sometimes feels like the case.
Sodium–glucose cotransporter-2 inhibitors may also reduce gout-related emergency department visits and hospitalizations, as well as provide cardiovascular benefits.
